FDA Fast-Tracks Psychedelic Drugs for Depression: Potential Approval by Summer 2021
The FDA has granted expedited review to three experimental psychedelic drugs, including psilocybin for depression, under the Trump administration’s pr...
The FDA has granted expedited review to three experimental psychedelic drugs, including psilocybin for depression, under the Trump administration’s pr...
The Trump administration is poised to reclassify marijuana as a Schedule III drug as early as Wednesday, according to an administration official. The...